105
Views
22
CrossRef citations to date
0
Altmetric
Original Research

Long Non-Coding RNA-NEAT1 Promotes Cell Migration and Invasion via Regulating miR-124/NF-κB Pathway in Cervical Cancer

ORCID Icon, , &
Pages 3265-3276 | Published online: 17 Apr 2020

References

  • Tsikouras P, Zervoudis S, Manav B, et al. Cervical cancer: screening, diagnosis and staging. J BUON. 2016;21:320–325.27273940
  • Mazdziarz A, Wygledowski J, Osuch B, et al. New directions in cervical cancer prophylaxis worldwide and in Poland – case study of the polish rural female population. Ann Agric Environ Med. 2017;24(4):592–595. doi:10.5604/12321966.123209329284230
  • Ronco G, Franceschi S. Cervical cancer screening: the transformational role of routine human papillomavirus testing. Ann Intern Med. 2018;168(1):75–76. doi:10.7326/M17-287229181508
  • Zhang YY, Li M, Xu YD, et al. LncRNA SNHG14 promotes the development of cervical cancer and predicts poor prognosis. Eur Rev Med Pharmacol Sci. 2019;23:3664–3671. doi:10.26355/eurrev_201905_1779031114991
  • Yee GP, de Souza P, Khachigian LM. Current and potential treatments for cervical cancer. Curr Cancer Drug Targets. 2013;13(2):205–220. doi:10.2174/156800961131302000923259831
  • Taheri M, Omrani MD, Ghafouri-Fard S. Long non-coding RNA expression in bladder cancer. Biophys Rev. 2018;10(4):1205–1213. doi:10.1007/s12551-017-0379-y29222807
  • Nikpayam E, Tasharrofi B, Sarrafzadeh S, et al. The role of long non-coding RNAs in ovarian cancer. Iran Biomed J. 2017;21(1):3–15. doi:10.18869/acadpub.ibj.21.1.327664137
  • Jiang C, Li X, Zhao H, et al. Long non-coding RNAs: potential new biomarkers for predicting tumor invasion and metastasis. Mol Cancer. 2016;15(1):62. doi:10.1186/s12943-016-0545-z27686732
  • Chen L, Dzakah EE, Shan G. Targetable long non-coding RNAs in cancer treatments. Cancer Lett. 2018;418:119–124. doi:10.1016/j.canlet.2018.01.04229341880
  • Zheng JJ, Du XJ, Wang HP, et al. Long non-coding RNA 00152 promotes cell proliferation in cervical cancer via regulating miR-216b-5p/HOXA1 axis. Eur Rev Med Pharmacol Sci. 2019;23:3654–3663. doi:10.26355/eurrev_201905_1778931114990
  • Cao L, Jin H, Zheng Y, et al. DANCR-mediated microRNA-665 regulates proliferation and metastasis of cervical cancer through the ERK/SMAD pathway. Cancer Sci. 2019;110:913–925. doi:10.1111/cas.1392130582654
  • Guo HM, Yang SH, Zhao SZ, et al. LncRNA NEAT1 regulates cervical carcinoma proliferation and invasion by targeting AKT/PI3K. Eur Rev Med Pharmacol Sci. 2018;22:4090–4097. doi:10.26355/eurrev_201807_1540030024596
  • Bartel DP. Bartel DP MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–297. doi:10.1016/s0092-8674(04)00045-514744438
  • Lin JF, Zeng H, Zhao JQ. MiR-212-5p regulates the proliferation and apoptosis of AML cells through targeting FZD5. Eur Rev Med Pharmacol Sci. 2018;22:8415–8422. doi:10.26355/eurrev_201812_1654030556883
  • Liu L, Ren W, Chen K. MiR-34a promotes apoptosis and inhibits autophagy by targeting HMGB1 in acute myeloid leukemia cells. Cell Physiol Biochem. 2017;41(5):1981–1992. doi:10.1159/00047527728478444
  • Liang YJ, Wang QY, Zhou CX, et al. MiR-124 targets slug to regulate epithelial-mesenchymal transition and metastasis of breast cancer. Carcinogenesis. 2013;34:713–722. doi:10.1093/carcin/bgs38323250910
  • Wang X, Wu Q, Xu B, et al. MiR-124 exerts tumor suppressive functions on the cell proliferation, motility and angiogenesis of bladder cancer by fine-tuning UHRF1. FEBS J. 2015;282(22):4376–4388. doi:10.1111/febs.1350226310391
  • Liz J, Esteller M. lncRNAs and microRNAs with a role in cancer development. Biochim Biophys Acta. 2016;1859(1):169–176. doi:10.1016/j.bbagrm.2015.06.01526149773
  • Yoon JH, Abdelmohsen K, Gorospe M. Functional interactions among microRNAs and long noncoding RNAs. Semin Cell Dev Biol. 2014;34:9–14. doi:10.1016/j.semcdb.2014.05.01524965208
  • Cheng N, Guo Y. Long noncoding RNA NEAT1 promotes nasopharyngeal carcinoma progression through regulation of miR-124/NF-kappaB pathway. Onco Targets Ther. 2017;10:5843–5853. doi:10.2147/OTT.S15180029270022
  • Gao D, Lv AE, Li HP, et al. LncRNA MALAT-1 elevates HMGB1 to promote autophagy resulting in inhibition of tumor cell apoptosis in multiple myeloma. J Cell Biochem. 2017;118:3341–3348. doi:10.1002/jcb.2598728295550
  • Jiang H, Liang M, Jiang Y, et al. The lncRNA TDRG1 promotes cell proliferation, migration and invasion by targeting miR-326 to regulate MAPK1 expression in cervical cancer. Cancer Cell Int. 2019;19(1):152. doi:10.1186/s12935-019-0872-431164797
  • Zhu Y, Liu B, Zhang P, et al. LncRNA TUSC8 inhibits the invasion and migration of cervical cancer cells via miR-641/PTEN axis. Cell Biol Int. 2019;43(7):781–788. doi:10.1002/cbin.1115231033083
  • Liu X, Yang Q, Yan J, et al. LncRNA MNX1-AS1 promotes the progression of cervical cancer through activating MAPK pathway. J Cell Biochem. 2019;120(3):4268–4277. doi:10.1002/jcb.2771230302806
  • Yan SP, Chu DX, Qiu HF, et al. LncRNA LINC01305 silencing inhibits cell epithelial-mesenchymal transition in cervical cancer by inhibiting TNXB-mediated PI3K/Akt signalling pathway. J Cell Mol Med. 2019;23:2656–2666. doi:10.1111/jcmm.1416130697971
  • Song C, Zhu S, Wu C, et al. Histone deacetylase (HDAC) 10 suppresses cervical cancer metastasis through inhibition of matrix metalloproteinase (MMP) 2 and 9 expression. J Biol Chem. 2013;288(39):28021–28033. doi:10.1074/jbc.M113.49875823897811
  • Escarcega RO, Fuentes-Alexandro S, Garcia-Carrasco M, et al. The transcription factor nuclear factor-kappa B and cancer. Clin Oncol (R Coll Radiol). 2007;19(2):154–161. doi:10.1016/j.clon.2006.11.01317355113
  • Huang W, Cui X, Chen J, et al. Long non-coding RNA NKILA inhibits migration and invasion of tongue squamous cell carcinoma cells via suppressing epithelial-mesenchymal transition. Oncotarget. 2016;7(38):62520–62532. doi:10.18632/oncotarget.1152827613832
  • Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev. 2004;18:2195–2224. doi:10.1101/gad.122870415371334
  • Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol. 2000;18:621–663. doi:10.1146/annurev.immunol.18.1.62110837071
  • Wang Y, Lin Z, Sun L, et al. Akt/Ezrin Tyr353/NF-kappaB pathway regulates EGF-induced EMT and metastasis in tongue squamous cell carcinoma. Br J Cancer. 2014;110:695–705. doi:10.1038/bjc.2013.77024346284
  • Simeone P, Trerotola M, Franck J, et al. The multiverse nature of epithelial to mesenchymal transition. Semin Cancer Biol. 2019;58:1–10. doi:10.1016/j.semcancer.2018.11.00430453041
  • Wang T, Shi F, Wang J, et al. Kallistatin suppresses cell proliferation and invasion and promotes apoptosis in cervical cancer through blocking NF-kappaB signaling. Oncol Res. 2017;25:809–817. doi:10.3727/096504016X1479918077823327983915
  • Fan MJ, Zou YH, He PJ, et al. Long non-coding RNA SPRY4-IT1 promotes epithelial-mesenchymal transition of cervical cancer by regulating the miR-101-3p/ZEB1 axis. Biosci Rep. 2019;39. doi:10.1042/BSR20181339
  • Pastushenko I, Blanpain C. EMT transition states during tumor progression and metastasis. Trends Cell Biol. 2019;29(3):212–226. doi:10.1016/j.tcb.2018.12.00130594349
  • Li X, Wang S, Li Z, et al. The lncRNA NEAT1 facilitates cell growth and invasion via the miR-211/HMGA2 axis in breast cancer. Int J Biol Macromol. 2017;105:346–353. doi:10.1016/j.ijbiomac.2017.07.05328720546